OrbiMed

OrbiMed (also known as OrbiMed Advisors) is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered to be one of the largest dedicated healthcare investment firms in the world.[3]

OrbiMed Advisors LLC
FormerlyMehta & Isaly
TypePrivate
IndustryInvestment management
Founded1989 (1989)
FounderSamuel Isaly
Michael Sheffery
Arvind Desai
HeadquartersCitigroup Center, New York City, New York, U.S.
ProductsPublic equity
Private equity
Venture capital
Private credit
AUMUS$21 billion (31 March 2021)
Number of employees
100[1]
Websitewww.orbimed.com
Footnotes / references
[2]

Background

In 1989, S.G Warburg pharmaceutical analysts, Viren Mehta and Samuel Isaly founded Mehta & Isaly, a money-management and research firm. This was the predecessor firm to OrbiMed.[3][4][5][6][7]

The firm made its first venture capital investment in 1993.[7]

In 1998, Mehta & Isaly split up where Mehta would form Mehta Partners and Isaly would form OrbiMed.[3][5][8]

In 2007, OrbiMed expanded into Asia opening offices in Shanghai and Mumbai and in 2010, expanded into the Middle East opening a office in Herzliya, Israel.[9]

In December 2017, Isaly stepped down from his role as managing partner of OrbiMed due to allegations of sexual harassment by former female employees of OrbiMed.[4][7][10][11]

Notable investments

References

  1. "Sponsors for the 13th ELSF Forum". SachsForum.
  2. "Form ADV as of 3/30/2021" (PDF). SEC.gov.
  3. "Orbimed drug portfolio balances prognosis with prevention". Institutional Investor. 2009-09-22. Retrieved 2023-07-15.
  4. "ObriMed Advisors founder to step down, be replaced by management committee". Pensions & Investments. 2017-12-08. Retrieved 2021-05-22.
  5. "Mehta & Isaly Investment Firm Splits". The New York Times. 1998-01-06. ISSN 0362-4331. Retrieved 2021-05-22.
  6. Kreutzer, Laura. "OrbiMed Seeks $4.75 Billion for Fresh Slate of Healthcare-Focused Funds". WSJ. Retrieved 2023-07-15.
  7. McElhaney, Alicia (2018-01-03). "Their Hedge Fund's Founder Was Accused of Sexual Harassment. Here's What They Did Next". Institutional Investor. Retrieved 2023-07-15.
  8. "OrbiMed Advisors". FierceBiotech. 8 October 2014. Retrieved 2021-05-22.
  9. "ORBIMED ADVISORS LLC Profile and Investing Strategy - GuruFocus.com". www.gurufocus.com. Retrieved 2021-05-22.
  10. "Isaly steps down from hedge fund giant OrbiMed after harassment claims". STAT. 2017-12-08. Retrieved 2021-05-22.
  11. Norton, Leslie P. "OrbiMed's Sam Isaly Steps Down Amid Accusations of Sexual Misconduct". www.barrons.com. Retrieved 2021-05-22.
  12. "AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform". www.abcellera.com. Retrieved 2021-05-22.
  13. Baum, Stephanie (2013-11-01). "OrbiMed closes its largest VC fund, predicts rebound in healthcare investing in 2014". MedCity News. Retrieved 2021-05-22.
  14. "Ambit Biosciences Completes $30 Million Series D-2 Financing". www.businesswire.com. 2011-06-10. Retrieved 2021-05-22.
  15. "BRIEF-Orbimed Advisors acquired 480,000 common shares of Cynapsus Therapeutics". Reuters. 2016-07-07. Retrieved 2021-05-22.
  16. "DFine raises $36.2M to repair spine fractures". VentureBeat. 2010-07-16. Retrieved 2021-05-22.
  17. Says, Anon (2008-01-03). "Xconomy: Obesity Startup Gelesis Gobbles Up $16M in Financing". Xconomy. Retrieved 2021-05-22.
  18. "Intercept Pharmaceuticals Closes $30 Million Series C Financing". www.prnewswire.com (Press release). Retrieved 2021-05-22.
  19. "Natera Completes $54.6 Million Financing to Support Expansion, Continued Global Rollout of Non-Invasive Prenatal Test Panorama™ | Natera, Inc". investor.natera.com. Retrieved 2021-05-22.
  20. Hay, Timothy (2012-08-28). "OmniGuide Raises $35M in Debt From OrbiMed Advisors". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-05-22.
  21. "TigerText Closes on $50 Million in Financing to Accelerate Growth; Launches TigerText Anywhere Initiative". TigerConnect. Retrieved 2021-05-22.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.